IN BRIEF (Page 19)

Plavix does work for heart patients

Patients with heart failure who have had a heart attack but have not had artery-clearing angioplasty treatment are less likely to die early if they take Sanofi-Aventis and Bristol-Myers Squibb's drug Plavix, new research shows.

The study by Danish scientists published in the Journal of the American College of Cardiology was the first to look at the effect of the anti-clotting drug Plavix, known generically as clopidogrel, on death rates in specific high-risk patients with heart failure and heart attack.